“ACO-SWITCH is a prospective study in adults with ATTR-CM,” wrote the researchers. “The study will determine the effects of ...
The FDA approved daraxonrasib (Rasonque), the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a ...
Medicare Part D changes, premium stabilization expiration, and a Bridge demonstration converge with rising GLP-1 demand and costs. Medicare Part D plans are running out of easy ways to absorb the cost ...
One in 5 adults with newly diagnosed moderate to severe plaque psoriasis maintained clear or almost-clear skin a full year ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results